PL2903589T3 - Wodna sterylna formulacja do wstrzykiwania na bazie usieciowanego kwasu hialuronowego i hydroksyapatytu do stosowania estetycznego - Google Patents

Wodna sterylna formulacja do wstrzykiwania na bazie usieciowanego kwasu hialuronowego i hydroksyapatytu do stosowania estetycznego

Info

Publication number: PL2903589T3
Authority: PL; Poland
Prior art keywords: hydroxyapatite; hyaluronic acid; sterile aqueous; aqueous formulation; crosslinked hyaluronic
Prior art date: 2012-10-08

Application number

PL13766322T

Other languages

English (en)

Inventor

Samuel Gavard Molliard

Original Assignee

Anteis Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-08

Filing date

2013-09-24

Publication date

2018-08-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47295066&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2903589(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-09-24 Application filed by Anteis Sa filed Critical Anteis Sa

2018-08-31 Publication of PL2903589T3 publication Critical patent/PL2903589T3/pl

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
239000013011 aqueous formulation Substances 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
229910052588 hydroxylapatite Inorganic materials 0.000 title 1
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Birds (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Gerontology & Geriatric Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Dispersion Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Materials For Medical Uses (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL13766322T 2012-10-08 2013-09-24 Wodna sterylna formulacja do wstrzykiwania na bazie usieciowanego kwasu hialuronowego i hydroksyapatytu do stosowania estetycznego PL2903589T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR1259577		2012-10-08
PCT/EP2013/069874 WO2014056722A2 (fr)	2012-10-08	2013-09-24	Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage esthétique
EP13766322.5A EP2903589B1 (fr)	2012-10-08	2013-09-24	Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage esthétique

Publications (1)

Publication Number	Publication Date
PL2903589T3 true PL2903589T3 (pl)	2018-08-31

Family

ID=47295066

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13766322T PL2903589T3 (pl)	2012-10-08	2013-09-24	Wodna sterylna formulacja do wstrzykiwania na bazie usieciowanego kwasu hialuronowego i hydroksyapatytu do stosowania estetycznego

Country Status (21)

Country	Link
US (2)	US20150257989A1 (pl)
EP (1)	EP2903589B1 (pl)
JP (1)	JP6342906B2 (pl)
KR (1)	KR101773989B1 (pl)
CN (1)	CN104703582B (pl)
AR (1)	AR092933A1 (pl)
AU (1)	AU2013329751B2 (pl)
BR (1)	BR112015007772B1 (pl)
CA (1)	CA2887316C (pl)
ES (1)	ES2668689T3 (pl)
IL (1)	IL237848B (pl)
IN (1)	IN2015DN02298A (pl)
LT (1)	LT2903589T (pl)
MX (1)	MX360833B (pl)
PL (1)	PL2903589T3 (pl)
RU (1)	RU2648450C2 (pl)
SG (1)	SG11201502743PA (pl)
TR (1)	TR201807119T4 (pl)
TW (1)	TWI641393B (pl)
WO (1)	WO2014056722A2 (pl)
ZA (1)	ZA201501697B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2014056723A1 (fr) *	2012-10-08	2014-04-17	Anteis S.A.	Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage thérapeutique
US10463762B2 (en) *	2012-10-08	2019-11-05	Anteis S.A.	Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use
TWI716365B (zh) *	2014-11-13	2021-01-21	德商梅茲製藥有限兩合公司	注射型真皮填充劑組合物及其套組、製備方法、與使用
FR3036035B1 (fr) *	2015-05-11	2018-10-05	Laboratoires Vivacy	Compositions comprenant au moins un polyol et au moins un anesthesique
US10004824B2 (en)	2015-05-11	2018-06-26	Laboratoires Vivacy	Compositions comprising at least one polyol and at least one anesthetic
JP6660469B2 (ja)	2015-11-24	2020-03-11	ビーエムアイコリアカンパニーリミテッド	ヒアルロン酸誘導体およびｄｎａ分画物が含まれているヒアルロン酸注射用組成物およびその利用
FR3044557B1 (fr) *	2015-12-07	2017-12-01	Benedicte Vincente Gavard Molliard Tauzin	Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
KR101886413B1 (ko) *	2016-03-16	2018-08-10	주식회사 엘앤씨바이오	히알루론산에 기반한 연조직 충진 조성물의 제조 방법
CA3032063A1 (en)	2016-07-27	2018-02-01	Marbelle Threads Ltd.	Threads of cross-linked hyaluronic acid and hydroxyapatite
CA3035153A1 (en)	2016-09-07	2018-03-15	Luminera Derm Ltd.	Injectable gels comprising cross-linked hyaluronic acid and hydroxyapatite, and methods of manufacturing thereof
IT201700008651A1 (it) *	2017-01-26	2018-07-26	Beauty System Pharma Ltd	Acido ialuronico reticolato con agenti reticolanti di tipo naturale o semisintetico
AU2018290810C1 (en)	2017-06-26	2024-09-12	Evolved By Nature, Inc.	Silk-hyaluronic acid based tissue fillers and methods of using the same
CN107496990A (zh) *	2017-08-15	2017-12-22	广东泰宝医疗器械技术研究院有限公司	一种可注射的抗菌软骨修复水凝胶及其制备方法
EP3694569B1 (en)	2017-10-10	2025-06-18	E.N.A. Impeccable Skincare Solutions Ltd	Method of manufacturing and dermal filler compositions containing hyaluronic acid and hydroxyapatite
WO2019182745A1 (en)	2018-03-19	2019-09-26	Bryn Pharma, LLC	Epinephrine spray formulations
WO2019197608A1 (en)	2018-04-13	2019-10-17	Merz Pharma Gmbh & Co. Kgaa	Dermal filler based on crosslinked hyaluronic acid, calcium phosphate material particles and carboxymethyl cellulose, a process for preparing same and uses thereof
CN108744054A (zh) *	2018-06-15	2018-11-06	北京水元生生物科技有限公司	一种注射型美容整形用面部填充剂组合物凝胶及其制备方法
WO2020095079A1 (fr) *	2018-11-06	2020-05-14	Kylane Laboratoires Sa	Composition injectable contenant de l'acide hyaluronique pour des applications au niveau du corps
CN111166686A (zh) *	2018-11-12	2020-05-19	无锡市伙伴日化科技有限公司	一种玻尿酸爽肤水
BR112021012141A2 (pt)	2018-12-19	2021-08-31	Evolved By Nature, Inc.	Preenchimento de tecido biocompatível, método de tratamento de uma condição em um sujeito em necessidade do mesmo e método de tratamento cosmético em um sujeito em necessidade do mesmo
EP4099978A1 (en) *	2020-02-06	2022-12-14	Merz Pharma GmbH & Co. KGaA	Injectable composition for skin and soft tissue augmentation
KR102686600B1 (ko) *	2021-08-05	2024-07-19	주식회사 바이오비쥬	가교 히알루론산을 포함하는 화장료 조성물 및 이의 제조방법
US20250114281A1 (en) *	2022-01-18	2025-04-10	Korea Institute Of Science And Technology	Apatite for filler and filler composition comprising same
ES2947097A1 (es) *	2022-02-01	2023-08-01	Martinez Miguel Angel Gomariz	Metodo cosmetico de rejuvenecimiento de la piel
CN115137877A (zh) *	2022-03-25	2022-10-04	杭州诺嫣生物科技有限公司	注射型凝胶组合物及其制备方法和应用
CN116570765A (zh) *	2023-06-02	2023-08-11	河北优固生物科技有限公司	一种人体软组织填充材料及其制备方法
WO2025160811A1 (zh) *	2024-01-31	2025-08-07	上海睿星医疗器材有限公司	用于真皮填充的均质凝胶组合物及其制法和应用
CN118206089B (zh) *	2024-03-20	2024-11-26	上海倍尔康生物医学科技有限公司	一种羟基磷灰石微球及其制备方法和应用
CN119367616A (zh) *	2024-10-29	2025-01-28	德清奥维泰生物科技有限公司	一种交联透明质酸钠凝胶含多孔羟基磷灰石微球复合物及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6537574B1 (en) *	1992-02-11	2003-03-25	Bioform, Inc.	Soft tissue augmentation material
DE69331096T2 (de)	1992-02-28	2002-08-14	Cohesion Technologies, Inc.	Injektierbare, keramische verbindungen sowie verfahren zur deren herstellung und anwendung
JP5449638B2 (ja)	2002-07-31	2014-03-19	デンツプライインターナショナルインコーポレーテッド	多孔性粒子およびキャリアゲルを含む骨修復パテ
FR2850282B1 (fr)	2003-01-27	2007-04-06	Jerome Asius	Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
US20100004700A1 (en)	2008-03-05	2010-01-07	Neville Alleyne	Method of treating tissue with a suspenson of tricalcium hydroxyapatite microspheres
CN101596328A (zh)	2008-06-02	2009-12-09	山东省生物药物研究院	一种复合生物材料及其制备方法和应用
FR2938187B1 (fr) *	2008-11-07	2012-08-17	Anteis Sa	Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
FR2945949B1 (fr) *	2009-05-26	2011-05-13	Anteis Sa	Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
CN102695501A (zh)	2009-11-09	2012-09-26	聚光灯技术合伙有限责任公司	碎裂水凝胶
US8915043B2 (en) *	2011-05-25	2014-12-23	General Electric Company	Bolt connection for a wind tower lattice structure
ITAN20110138A1 (it) *	2011-10-12	2012-01-11	Regenyal Lab S R L	Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato.
WO2014056723A1 (fr)	2012-10-08	2014-04-17	Anteis S.A.	Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage thérapeutique

2013
- 2013-09-24 TR TR2018/07119T patent/TR201807119T4/tr unknown
- 2013-09-24 JP JP2015536048A patent/JP6342906B2/ja active Active
- 2013-09-24 RU RU2015115974A patent/RU2648450C2/ru active
- 2013-09-24 PL PL13766322T patent/PL2903589T3/pl unknown
- 2013-09-24 CN CN201380052596.3A patent/CN104703582B/zh active Active
- 2013-09-24 KR KR1020157009968A patent/KR101773989B1/ko active Active
- 2013-09-24 AU AU2013329751A patent/AU2013329751B2/en active Active
- 2013-09-24 WO PCT/EP2013/069874 patent/WO2014056722A2/fr not_active Ceased
- 2013-09-24 CA CA2887316A patent/CA2887316C/en active Active
- 2013-09-24 BR BR112015007772A patent/BR112015007772B1/pt active IP Right Grant
- 2013-09-24 EP EP13766322.5A patent/EP2903589B1/fr active Active
- 2013-09-24 MX MX2015004307A patent/MX360833B/es active IP Right Grant
- 2013-09-24 SG SG11201502743PA patent/SG11201502743PA/en unknown
- 2013-09-24 US US14/433,927 patent/US20150257989A1/en not_active Abandoned
- 2013-09-24 ES ES13766322.5T patent/ES2668689T3/es active Active
- 2013-09-24 LT LTEP13766322.5T patent/LT2903589T/lt unknown
- 2013-10-08 AR ARP130103635A patent/AR092933A1/es active IP Right Grant
- 2013-10-08 TW TW102136381A patent/TWI641393B/zh active
2015
- 2015-03-12 ZA ZA2015/01697A patent/ZA201501697B/en unknown
- 2015-03-19 IL IL237848A patent/IL237848B/en active IP Right Grant
- 2015-03-20 IN IN2298DEN2015 patent/IN2015DN02298A/en unknown
2018
- 2018-03-06 US US15/913,086 patent/US10493006B2/en active Active

Also Published As

Publication number	Publication date
RU2015115974A (ru)	2016-11-27
WO2014056722A3 (fr)	2014-07-10
ZA201501697B (en)	2016-11-30
EP2903589B1 (fr)	2018-04-18
US20180193232A1 (en)	2018-07-12
EP2903589A2 (fr)	2015-08-12
AU2013329751A1 (en)	2015-04-16
TR201807119T4 (tr)	2018-06-21
CA2887316A1 (en)	2014-04-17
LT2903589T (lt)	2018-06-11
CA2887316C (en)	2020-04-21
BR112015007772B1 (pt)	2020-05-05
AU2013329751B2 (en)	2017-12-21
AR092933A1 (es)	2015-05-06
IL237848A0 (en)	2015-05-31
MX2015004307A (es)	2015-08-20
US10493006B2 (en)	2019-12-03
IL237848B (en)	2019-07-31
HK1210429A1 (en)	2016-04-22
WO2014056722A2 (fr)	2014-04-17
RU2648450C2 (ru)	2018-03-26
CN104703582B (zh)	2017-11-24
IN2015DN02298A (pl)	2015-08-21
JP2015536911A (ja)	2015-12-24
BR112015007772A2 (pt)	2017-07-04
KR101773989B1 (ko)	2017-09-12
CN104703582A (zh)	2015-06-10
US20150257989A1 (en)	2015-09-17
KR20150064090A (ko)	2015-06-10
SG11201502743PA (en)	2015-05-28
JP6342906B2 (ja)	2018-06-13
ES2668689T3 (es)	2018-05-21
MX360833B (es)	2018-11-20
TW201427708A (zh)	2014-07-16
TWI641393B (zh)	2018-11-21

Publication	Publication Date	Title
IL237848B (en)	2019-07-31	Sterile aqueous injectable formulation based on cross-linked lauronic acid and hydroxyapatite for esthetic use
PT2912074T (pt)	2019-07-19	Composição estéril injetável dérmica
EP2858697A4 (en)	2017-07-05	Preventing inadvertent changes in ambulatory medical devices
ES3064200T3 (en)	2026-04-23	Risperidone implant formulation
HRP20190131T1 (hr)	2019-03-22	Farmaceutske formulacije koje sadrže hondroitin-sulfat i derivate hijaluronske kiseline
IL235858A0 (en)	2015-01-29	Devices and scaffolds for tissue repair
PL2934592T3 (pl)	2018-12-31	C6-c18-acylowana pochodna kwasu hialuronowego, sposób jej wytwarzania, mieszanina nanomicelarna na jej bazie, sposób jej wytwarzania oraz sposób wytwarzania stabilizowanej mieszanki nanomicelarnej i jej zastosowanie
EP2879593A4 (en)	2016-06-01	SYSTEMS AND METHODS FOR TISSUE REPAIR
IL237202A0 (en)	2015-04-30	A sterilized preparation containing at least one hyaluronic acid and magnesium ascorbyl phosphate
EP2858719A4 (en)	2017-04-19	Systems and methods for tissue treatment
ZA201502988B (en)	2016-11-30	A stable aqueous composition comprising human insulin or an analogue or derivative thereof
EP3071236A4 (en)	2017-05-24	Injectable tissue supplement
EP3081232A4 (en)	2017-06-14	Hyaluronic acid gel composition having sustained release property
ZA201503171B (en)	2016-11-30	Modified hyaluronic acid derivatives and use thereof
PT3021881T (pt)	2017-07-21	Ácido hialurónico reticulado, processo para a sua preparação e sua utilização no campo da estética
PL2983691T3 (pl)	2018-05-30	Synergistyczna kombinacja alanino-glutaminy, kwasu hialuronowego i wyciągu z owsa i jej zastosowanie w kompozycji przeznaczonej do zabliźniania ran i naprawiania uszkodzeń skóry
IL221087A (en)	2015-07-30	Pharmacy or nutritional composition
HUE044796T2 (hu)	2019-11-28	Gyógyászati készítmény hiperkoleszterinémia kezelésére
EP2832724A4 (en)	2015-09-23	NIPETIC ACID DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
GB201215502D0 (en)	2012-10-17	Medical use
EP2999336A4 (en)	2017-01-25	Indication and technique for the use of cross-linked hyaluronic acid in the management of pain
AU2012903976A0 (en)	2012-09-27	Skin Treatment Formulation
AU2012903356A0 (en)	2012-08-16	Improvements in Medical Treatment
GB201222619D0 (en)	2013-01-30	Surgical implant
GB201214541D0 (en)	2012-09-26	Skin treatment formulation, and use thereof